Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes

Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler, Alexandra E. Butler

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pancreatitis is more frequent in type 2 diabetes mellitus (T2DM), although the underlying cause is unknown. We tested the hypothesis that ongoing β cell stress and apoptosis in T2DM induces ductal tree proliferation, particularly the pancreatic duct gland (PDG) compartment, and thus potentially obstructs exocrine outflow, a well-established cause of pancreatitis. PDG replication was increased 2-fold in human pancreas from individuals with T2DM, and was associated with increased pancreatic intraepithelial neoplasia (PanIN), lesions associated with pancreatic inflammation and with the potential to obstruct pancreatic outflow. Increased PDG replication in the prediabetic human-IAPP-transgenic (HIP) rat model of T2DM was concordant with increased β cell stress but preceded metabolic derangement. Moreover, the most abundantly expressed chemokines released by the islets in response to β cell stress in T2DM, CXCL1, -4, and -10, induced proliferation in human pancreatic ductal epithelium. Also, the diabetes medications reported as potential modifiers for the risk of pancreatitis in T2DM modulated PDG proliferation accordingly. We conclude that chronic stimulation and proliferation of the PDG compartment in response to islet inflammation in T2DM is a potentially novel mechanism that serves as a link to the increased risk for pancreatitis in T2DM and may potentially be modified by currently available diabetes therapy.

Original languageEnglish (US)
JournalJCI insight
Volume2
Issue number13
DOIs
StatePublished - Jul 6 2017
Externally publishedYes

Fingerprint

Pancreatitis
Type 2 Diabetes Mellitus
Pancreatic Ducts
Inflammation
Transgenic Rats
Chemokines
Pancreas
Epithelium
Apoptosis
Neoplasms

Keywords

  • Endocrinology

Cite this

Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes. / Schludi, Belinda; Moin, Abu Saleh Md; Montemurro, Chiara; Gurlo, Tatyana; Matveyenko, Aleksey V; Kirakossian, David; Dawson, David W.; Dry, Sarah M.; Butler, Peter C.; Butler, Alexandra E.

In: JCI insight, Vol. 2, No. 13, 06.07.2017.

Research output: Contribution to journalArticle

Schludi, B, Moin, ASM, Montemurro, C, Gurlo, T, Matveyenko, AV, Kirakossian, D, Dawson, DW, Dry, SM, Butler, PC & Butler, AE 2017, 'Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes', JCI insight, vol. 2, no. 13. https://doi.org/10.1172/jci.insight.92282
Schludi, Belinda ; Moin, Abu Saleh Md ; Montemurro, Chiara ; Gurlo, Tatyana ; Matveyenko, Aleksey V ; Kirakossian, David ; Dawson, David W. ; Dry, Sarah M. ; Butler, Peter C. ; Butler, Alexandra E. / Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes. In: JCI insight. 2017 ; Vol. 2, No. 13.
@article{32129411cb0b4242a2d7f75857ba511b,
title = "Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes",
abstract = "Pancreatitis is more frequent in type 2 diabetes mellitus (T2DM), although the underlying cause is unknown. We tested the hypothesis that ongoing β cell stress and apoptosis in T2DM induces ductal tree proliferation, particularly the pancreatic duct gland (PDG) compartment, and thus potentially obstructs exocrine outflow, a well-established cause of pancreatitis. PDG replication was increased 2-fold in human pancreas from individuals with T2DM, and was associated with increased pancreatic intraepithelial neoplasia (PanIN), lesions associated with pancreatic inflammation and with the potential to obstruct pancreatic outflow. Increased PDG replication in the prediabetic human-IAPP-transgenic (HIP) rat model of T2DM was concordant with increased β cell stress but preceded metabolic derangement. Moreover, the most abundantly expressed chemokines released by the islets in response to β cell stress in T2DM, CXCL1, -4, and -10, induced proliferation in human pancreatic ductal epithelium. Also, the diabetes medications reported as potential modifiers for the risk of pancreatitis in T2DM modulated PDG proliferation accordingly. We conclude that chronic stimulation and proliferation of the PDG compartment in response to islet inflammation in T2DM is a potentially novel mechanism that serves as a link to the increased risk for pancreatitis in T2DM and may potentially be modified by currently available diabetes therapy.",
keywords = "Endocrinology",
author = "Belinda Schludi and Moin, {Abu Saleh Md} and Chiara Montemurro and Tatyana Gurlo and Matveyenko, {Aleksey V} and David Kirakossian and Dawson, {David W.} and Dry, {Sarah M.} and Butler, {Peter C.} and Butler, {Alexandra E.}",
year = "2017",
month = "7",
day = "6",
doi = "10.1172/jci.insight.92282",
language = "English (US)",
volume = "2",
journal = "JCI insight",
issn = "2379-3708",
publisher = "The American Society for Clinical Investigation",
number = "13",

}

TY - JOUR

T1 - Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes

AU - Schludi, Belinda

AU - Moin, Abu Saleh Md

AU - Montemurro, Chiara

AU - Gurlo, Tatyana

AU - Matveyenko, Aleksey V

AU - Kirakossian, David

AU - Dawson, David W.

AU - Dry, Sarah M.

AU - Butler, Peter C.

AU - Butler, Alexandra E.

PY - 2017/7/6

Y1 - 2017/7/6

N2 - Pancreatitis is more frequent in type 2 diabetes mellitus (T2DM), although the underlying cause is unknown. We tested the hypothesis that ongoing β cell stress and apoptosis in T2DM induces ductal tree proliferation, particularly the pancreatic duct gland (PDG) compartment, and thus potentially obstructs exocrine outflow, a well-established cause of pancreatitis. PDG replication was increased 2-fold in human pancreas from individuals with T2DM, and was associated with increased pancreatic intraepithelial neoplasia (PanIN), lesions associated with pancreatic inflammation and with the potential to obstruct pancreatic outflow. Increased PDG replication in the prediabetic human-IAPP-transgenic (HIP) rat model of T2DM was concordant with increased β cell stress but preceded metabolic derangement. Moreover, the most abundantly expressed chemokines released by the islets in response to β cell stress in T2DM, CXCL1, -4, and -10, induced proliferation in human pancreatic ductal epithelium. Also, the diabetes medications reported as potential modifiers for the risk of pancreatitis in T2DM modulated PDG proliferation accordingly. We conclude that chronic stimulation and proliferation of the PDG compartment in response to islet inflammation in T2DM is a potentially novel mechanism that serves as a link to the increased risk for pancreatitis in T2DM and may potentially be modified by currently available diabetes therapy.

AB - Pancreatitis is more frequent in type 2 diabetes mellitus (T2DM), although the underlying cause is unknown. We tested the hypothesis that ongoing β cell stress and apoptosis in T2DM induces ductal tree proliferation, particularly the pancreatic duct gland (PDG) compartment, and thus potentially obstructs exocrine outflow, a well-established cause of pancreatitis. PDG replication was increased 2-fold in human pancreas from individuals with T2DM, and was associated with increased pancreatic intraepithelial neoplasia (PanIN), lesions associated with pancreatic inflammation and with the potential to obstruct pancreatic outflow. Increased PDG replication in the prediabetic human-IAPP-transgenic (HIP) rat model of T2DM was concordant with increased β cell stress but preceded metabolic derangement. Moreover, the most abundantly expressed chemokines released by the islets in response to β cell stress in T2DM, CXCL1, -4, and -10, induced proliferation in human pancreatic ductal epithelium. Also, the diabetes medications reported as potential modifiers for the risk of pancreatitis in T2DM modulated PDG proliferation accordingly. We conclude that chronic stimulation and proliferation of the PDG compartment in response to islet inflammation in T2DM is a potentially novel mechanism that serves as a link to the increased risk for pancreatitis in T2DM and may potentially be modified by currently available diabetes therapy.

KW - Endocrinology

UR - http://www.scopus.com/inward/record.url?scp=85048673500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048673500&partnerID=8YFLogxK

U2 - 10.1172/jci.insight.92282

DO - 10.1172/jci.insight.92282

M3 - Article

C2 - 28679961

AN - SCOPUS:85048673500

VL - 2

JO - JCI insight

JF - JCI insight

SN - 2379-3708

IS - 13

ER -